Neurontin
In brief
- Neurontin (gabapentin) is a prescription-only medicine in the UK.
- Neurontin is used for partial (focal) seizures, neuropathic pain including postherpetic neuralgia and diabetic neuropathy. It is an anticonvulsant that binds the α2δ subunit of voltage‑gated calcium channels, reducing excitatory neurotransmitter release.
- Typical adult dosages vary by indication: epilepsy often starts at 300 mg on day one then titrated to 900–1,800 mg/day in three divided doses (some patients up to 3,600 mg/day for neuropathic pain); neuropathic pain commonly 1,800–3,600 mg/day in divided doses; doses should be adjusted for renal function and individual response.
- Administered orally as capsules or tablets, usually given in three divided doses.
- Oral gabapentin is usually absorbed and begins to take effect within 1–3 hours for acute symptomatic effects, though therapeutic benefit for neuropathic pain or seizure control may require dose titration and days to weeks to become apparent.
- The elimination half‑life is typically 5–7 hours for immediate‑release formulations, so effects commonly last around 6–8 hours (hence three-times-daily dosing).
- Do not drink alcohol while taking gabapentin as alcohol increases drowsiness, dizziness and the risk of respiratory depression, especially when combined with opioids or other CNS depressants.
- The most common side effects are dizziness and drowsiness (very common); other frequent effects include fatigue, peripheral oedema, ataxia/coordination problems, weight gain, nausea and behavioural changes in children.
- Would you like to try Neurontin without a prescription?
Legal status and availability in the UK
Neurontin (gabapentin) is a prescription-only medicine (POM) in the UK.
In our online pharmacy, Neurontin is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.
Basic Neurontin information
- INN (international nonproprietary name): Gabapentin
- Brand names available in the United Kingdom: Neurontin, generic gabapentin
- ATC code: N03AX12
- Forms and dosages: Capsules 100 mg, 300 mg, 400 mg; tablets 600 mg, 800 mg
- Manufacturers in the United Kingdom: Pfizer (Neurontin), Teva, Sandoz, Mylan/Viatris and others
- Registration status in the United Kingdom: Authorised for epilepsy and neuropathic pain
- OTC / Rx classification: Prescription-only medicine (POM)
Patients find gabapentin useful for several kinds of nerve pain and as adjunctive therapy for focal seizures.
Product snapshot and packaging
Key identifiers and ATC classification
International Nonproprietary Name: Gabapentin.
ATC Code: N03AX12, classed among “other antiepileptics” under nervous system medicines.
Originator brand: Neurontin (Pfizer).
Forms, dosages and typical packaging
Immediate‑release capsules are available in 100 mg, 300 mg and 400 mg strengths and commonly come in blister packs of 30 or 90.
Tablets such as 600 mg and 800 mg appear in blister or bottle formats where scored tablets are required.
| Form | Dosages | Typical pack sizing |
|---|---|---|
| Oral capsules | 100 mg, 300 mg, 400 mg | Blister packs 30 / 90 |
| Oral tablets | 600 mg, 800 mg | Blister / bottle, scored tablets |
Indications and approved uses
Licensed indications
Gabapentin is authorised for focal (partial) seizures as adjunctive therapy and for neuropathic pain such as postherpetic neuralgia and diabetic neuropathy.
Off-label uses commonly encountered
Clinicians and patients frequently discuss gabapentin for anxiety, fibromyalgia and chronic sciatica, though these uses are not universally authorised.
Off‑label prescribing is clinician‑led and should be guided by current evidence and specialist advice where appropriate.
- Epilepsy (partial/focal seizures)
- Typical starting dose: 300 mg day 1 with rapid titration to maintenance of 900–1800 mg/day; monitoring: seizure control and tolerability.
- Neuropathic pain (PHN, diabetic neuropathy)
- Typical starting dose: 300 mg, increase by 300 mg daily; maintenance often 1800–3600 mg/day divided; monitoring: pain score and side effects over weeks.
Dosing, titration and renal adjustments
Adult dosing schedules and titration
Standard immediate‑release titration often starts 300 mg on day 1, 300 mg twice on day 2 and 300 mg three times on day 3, progressing to 900–1800 mg/day in three divided doses for seizures.
For neuropathic pain, titration commonly continues up to 1800–3600 mg/day divided in three doses depending on effect and tolerability.
Paediatric, elderly and renal dosing considerations
Children aged three years and older: for epilepsy start at 10–15 mg/kg/day in three divided doses, increasing up to approximately 40 mg/kg/day as maintenance under specialist guidance.
Elderly patients require careful titration and dose selection because of increased sensitivity to dizziness and sedation.
Renal impairment requires significant dose reduction and extended dosing intervals because gabapentin is renally excreted and accumulates in dysfunction.
| Group | Typical starting dose | Max maintenance | Monitoring |
|---|---|---|---|
| Adults (Seizures) | 300 mg day 1, titrate to 900–1800 mg/day | Up to 1800 mg/day | Seizure frequency; sedation |
| Adults (Neuropathic Pain) | Start 300 mg, increase by 300 mg daily | 1800–3600 mg/day | Pain relief over weeks; side effects |
| Children (≥3 years) | 10–15 mg/kg/day in 3 doses | Up to 40 mg/kg/day | Growth, behaviour, infections |
| Renal Impairment | Individualised; consult SmPC dosing table | Adjusted to creatinine clearance | Renal function tests; signs of accumulation |
Contraindications and high-risk groups
Absolute contraindications
Absolute contraindication is known hypersensitivity to gabapentin or any excipient listed in the product leaflet.
Patients with previous severe allergic reactions to the active substance should not be given gabapentin.
Cautions and monitoring priorities
Renal insufficiency requires dose adjustment and clinical monitoring for toxicity because gabapentin is renally excreted.
Concurrent opioid use and severe respiratory disease raise the risk of life‑threatening respiratory depression; co‑prescription should be carefully reviewed.
Patients with a history of mood disorders should be monitored for new or worsening depression and suicidal ideation.
Pregnancy and lactation: use only if benefits justify risks and discuss referral to pregnancy exposure registries where available.
Elderly patients have increased fall and sedation risk and should have regular medication reviews if treated with gabapentin.
- Absolute: Hypersensitivity to gabapentin or excipients.
- Relative/caution: Renal impairment, respiratory disease, opioid co‑use, mood disorders, pregnancy/lactation.
Side effects, frequency and monitoring
Very common and common adverse effects
Very common adverse effects include dizziness and drowsiness/somnolence.
Common adverse effects include fatigue, peripheral oedema, ataxia or coordination problems, weight gain, nausea and vomiting.
Children commonly report viral infections and behavioural changes while taking gabapentin.
Most tolerability issues present within the early weeks of therapy and often improve with dose adjustment.
When to seek urgent care
Seek urgent care for signs of severe allergic reaction, swelling of the face or throat, severe skin reactions or breathing difficulties.
Urgent assessment is also needed for sudden severe drowsiness, marked respiratory depression—especially with opioids—or new severe mood changes and suicidal thoughts.
Monitoring recommendations include early review at 1–4 weeks to assess sedation and falls risk and periodic renal function checks for those with reduced kidney function.
| Adverse effect | Frequency | Typical onset | Management |
|---|---|---|---|
| Dizziness | Very common | Early weeks | Reduce dose or slow titration; caution with driving |
| Drowsiness | Very common | Early weeks | Avoid CNS depressants; review regimen |
| Peripheral Oedema | Common | Weeks | Assess cardiovascular/renal causes; consider alternative |
Drug interactions and polypharmacy risks
Major drug interaction warnings
Gabapentin has minimal pharmacokinetic interactions because it is not substantially metabolised, but pharmacodynamic interactions are important.
Concomitant CNS depressants such as opioids, benzodiazepines and alcohol increase sedation and respiratory depression risk.
Antacids that contain aluminium or magnesium can reduce gabapentin absorption if taken at the same time; separating doses by a couple of hours is advisable.
Care is required when switching between pregabalin and gabapentin or when altering other antiepileptic regimens to maintain seizure control.
Practical checks
Check renal function before dispensing where kidney disease is known or suspected and adjust the dose accordingly.
Review the patient’s list of CNS depressants and counsel regarding alcohol avoidance while taking gabapentin.
| Drug | Risk | Action |
|---|---|---|
| Opioids | Increased respiratory depression and sedation | Review necessity; warn patient; consider seeking specialist advice |
| Benzodiazepines | Increased sedation | Advise caution with driving; consider dose review |
| Antacids | Reduced absorption if co‑administered | Separate dosing by 2 hours |
Practical use: starting, missed doses, stopping
Counselling at initiation
Start with a low titration schedule to reduce dizziness and somnolence and explain the planned dose increases.
Immediate‑release gabapentin is usually taken three times daily; follow the product instructions.
Gabapentin may be taken with or without food and the oral solution should be dosed with the supplied syringe for accuracy.
Missed dose and discontinuation guidance
If a dose is missed, take it as soon as remembered unless it is near the next dose—do not double up.
Abrupt discontinuation is not advised because it can precipitate withdrawal seizures or symptom relapse; taper under clinician guidance over at least 1–2 weeks or longer if indicated.
Storage advice: store at 20–25°C, protect from moisture; check bottle label for any special instructions for the oral solution.
Overdose can cause drowsiness, slurred speech and lethargy; severe toxicity, particularly in renal impairment, may require supportive care and haemodialysis.
Alternatives to gabapentin
Key alternatives
Pregabalin (Lyrica) is closely related and shares indications for neuropathic pain and focal seizures, with different pharmacokinetics.
Other antiepileptics such as carbamazepine, lamotrigine and topiramate are alternatives for seizure control with distinct efficacy and side‑effect profiles.
For neuropathic pain, antidepressants like duloxetine and amitriptyline remain first‑line options in some pathways and provide an alternative mechanism.
When gabapentin is a reasonable choice
Gabapentin is a reasonable choice when prior patient response favours it and when renal function can be accounted for in dosing.
| Drug | Indications | Onset | Key cautions |
|---|---|---|---|
| Gabapentin | Neuropathic pain, adjunct for focal seizures | Days to weeks for pain, variable for seizure control | Renal dosing; sedation |
| Pregabalin | Neuropathic pain, epilepsy | Often rapid symptom improvement | Similar sedation risks; adjust renal dose |
Brand and generic gabapentin
Originator and generic considerations
Pfizer remains the originator supplier for Neurontin but numerous generics are available from established manufacturers such as Teva, Sandoz, Mylan/Viatris, KRKA, Torrent and others.
Generics are approved as bioequivalent and are the norm on many formularies, though some patients report perceived changes in efficacy or tolerability on switching and merit review.
Packaging differences
Packaging varies between brands and generics, including blister formats, bottle presentations and differing excipients and colouring.
| Brand | Typical Dosages | Common manufacturers |
|---|---|---|
| Neurontin | 100 mg–800 mg formulations | Pfizer |
| Generic Gabapentin | 100 mg–800 mg formulations | Teva, Sandoz, Mylan/Viatris, KRKA and others |
Counselling points and FAQs
Key counselling points
Warn patients not to drive or operate machinery until they know how gabapentin affects them because dizziness and drowsiness are common.
Advise avoidance of alcohol and to review all sedating medicines with the pharmacist.
Emphasise the need to report mood changes or suicidal thoughts promptly and to keep regular clinician reviews, especially in people with psychiatric histories.
Explain renal dose relevance and that blood tests are only needed when clinically indicated.
FAQs
Can I drive on gabapentin? Answer: Not until you know how it affects you; avoid driving if drowsy or dizzy.
What if I miss a dose? Answer: Take as soon as you remember unless it is near the next dose; do not double doses.
Can I drink alcohol? Answer: Avoid alcohol as it increases sedation and respiratory risk with gabapentin.
How long until it works for nerve pain? Answer: Pain benefit often emerges over days to weeks with gradual titration.
Delivery across the United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | England | 9–21 days |
| Birmingham | England | 9–21 days |
| Manchester | England | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Leeds | England | 9–21 days |
| Liverpool | England | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Bristol | England | 9–21 days |
| Sheffield | England | 9–21 days |
| Newcastle upon Tyne | England | 9–21 days |
| Belfast | Northern Ireland | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Coventry | England | 9–21 days |
| Nottingham | England | 9–21 days |
| Plymouth | England | 9–21 days |
